OBJECTIVE: Campylobacter jejuni NCTC11168 is commonly used as a standard strain for flagellar biosynthesis research. In this report, two distinguished phenotypic isolates (CJ1Z, flhA mutant strain, lawn; CJ2S, flhA complemented strain, normal colony) appeared during laboratory passages for NCTC11168. METHODS: Phenotypic assessments, including motility plates, transmission electron microscopy, biofilm formation assay, autoagglutination assay, and genome re-sequencing for these two isolates (CJ1Z, flhA mutant strain; CJ2S, flhA complemented strain) were carried out in this study. RESULTS: Transmission electron microscopy revealed that the flagellum was lost in CJ1Z. Phenotypic assessments and genome sequencing of the two isolates were performed in this study. The capacity for biofilm formation, colony auto-agglutination, and isolate motility was reduced in the mutant CJ1Z. Comparative genomic analysis indicated a unique native nucleotide insertion in flhA (nt, 2154) that caused the I719Y and I720Y mutations and early truncation in flhA. CONCLUSION FlhA has been found to influence the expression of flagella in C. jejuni. To the best of our knowledge, this is the first study to describe the function of the C-terminal of this protein.
Campylobacter jejuni/genetics* ; Bacterial Proteins/metabolism* ; Mutation ; Biological Variation, Population

BACKGROUND: Campylobacter jejuni is an important food-borne pathogen that causes human gastroenteritis. This study was conducted to investigate the incidence of isolation, antimicrobial susceptibility pattern, and C. jejuni genotype from diarrhea patients in Busan, Korea. METHODS: A total of 97 C. jejuni were isolated from diarrhea patients during five food-borne outbreaks from 2014 to September 2017. Antimicrobial susceptibility tests were carried out by the broth microdilution method for ciprofloxacin (CIP), nalidixic acid (NAL), tetracycline (TET), chloramphenicol, azithromycin (AZI), erythromycin (ERY), streptomycin (STR), gentamicin, and telithromycin. To investigate C. jejuni genotypes, pulsed-field gel electrophoresis (PFGE) profile analysis was performed. RESULTS: The isolation rate of C. jejuni was 2.0% for the last 4 years and increased annually. Antimicrobial resistance rates of C. jejuni were shown to be in the order of NAL (90.9%), CIP (89.4%), TET (13.6%), AZI (3.0%), ERY (3.0%), and STR (1.5%). The proportion of multidrug-resistance was 18.2%, and they commonly contained quinolones (CIP-NAL). Analysis of PFGE patterns of SmaI-restricted DNA of C. jejuni isolates showed 17 clusters; cluster 11 was the major genotype pattern. CONCLUSION: This study will provide useful data for the proper use of antimicrobials and the management of resistant C. jejuni. Also it will help to provide data for the epidemiological investigation of foodborne diseases caused by C. jejuni, which is expected to increase in the future.
Azithromycin ; Busan ; Campylobacter jejuni ; Campylobacter ; Chloramphenicol ; Ciprofloxacin ; Diarrhea ; Disease Outbreaks ; DNA ; Electrophoresis, Gel, Pulsed-Field ; Erythromycin ; Foodborne Diseases ; Gastroenteritis ; Genotype ; Gentamicins ; Humans ; Incidence ; Korea ; Methods ; Nalidixic Acid ; Quinolones ; Streptomycin ; Tetracycline

Campylobacter coli/isolation & purification* ; Campylobacter jejuni/isolation & purification*

Recurrent Guillain-Barré syndrome (GBS) is a rare, immune-mediated disease of the peripheral nervous system. It has been reported to occur at intervals ranging from four months to 10 years; published case studies suggest that 1%–6% of patients who have had GBS will experience recurrent attacks. The most commonly identified infections coinciding with GBS are Campylobacter jejuni, Haemophilus influenzae, Mycoplasma pneumonia, and cytomegalovirus, while an antecedent infection with Escherichia coli is very uncommon. In this case report, we present a rare episode of recurrent GBS, which followed a urinary tract infection (UTI) by E. coli, and an accompanying literature review. A 75-year-old woman with a prior history of acute motor axonal neuropathy (AMAN), a subtype of GBS, presented with subsequent weakness of limbs and areflexia following 10 days of fever, frequency, and dysuria. Base on nerve conduction studies, cerebrospinal fluid analysis and other clinical investigation, we diagnosed the patient with recurrent GBS caused by E. coli. The patient recovered with mild subjective weakness following treatment of intravenous immunoglobulin with ceftriaxone. We suggest that E. coli causes UTI could be one of the diverse trigger factors involved in recurrent GBS.
Aged ; Axons ; Campylobacter jejuni ; Ceftriaxone ; Cerebrospinal Fluid ; Cytomegalovirus ; Dysuria ; Escherichia coli ; Escherichia ; Extremities ; Female ; Fever ; Guillain-Barre Syndrome ; Haemophilus influenzae ; Humans ; Immunoglobulins ; Neural Conduction ; Peripheral Nervous System ; Pneumonia, Mycoplasma ; Polyneuropathies ; Urinary Tract Infections ; Urinary Tract ; Uropathogenic Escherichia coli

Campylobacter infection causes gastrointestinal symptoms such as abdominal pain or diarrhea. Occasionally, Campylobacter bacteremia affects immunocompromised patients; however, serious outcomes are known to be rare. Here, we present a case of a patient with Campylobacter bacteremia who had underlying liver cirrhosis. The patient had fever and diarrhea. These symptoms subsided after treatment with cefotaxime. Campylobacter jejuni was isolated in the blood culture after 10 days. In addition, previously reported cases of Campylobacter bacteremia in Asian countries were reviewed with respect to antimicrobial sensitivities.
Abdominal Pain ; Asian Continental Ancestry Group ; Bacteremia* ; Campylobacter Infections ; Campylobacter jejuni* ; Campylobacter* ; Cefotaxime ; Diarrhea ; Fever ; Humans ; Immunocompromised Host ; Liver Cirrhosis* ; Liver*

PURPOSE: To report a case of Miller Fisher syndrome in a pediatric patient with gastroenteritis associated with seroconversion of Campylobacter jejuni titer during the development of neurological symptoms and positive anti-GQ1b IgG. CASE SUMMARY: An 8-year-old male patient visited our clinic with bilateral ophthalmoplegia, diplopia, and ptosis of the right upper lid. He had experienced gastroenteritis one week previous, and antibodies to Campylobacter jejuni were detected in his plasma. Ophthalmic examination revealed a corrected visual acuity of 20/20 in both eyes. Ocular motor examination revealed limitations in all positions of gaze. Neurologic examination demonstrated areflexia and ataxia. The serologic anti-GQ1b IgG test was positive. Intravenous immunoglobulin and steroid pulse therapy were started. Extraocular movement, ptosis, and ataxia gradually improved after one month of treatment. CONCLUSIONS: We confirmed a case of Miller Fisher syndrome in a pediatric patient with bilateral ophthalmoplegia, ptosis, and a positive anti-GQ1b antibody test.
Antibodies ; Ataxia ; Campylobacter jejuni ; Child ; Diplopia ; Gastroenteritis ; Humans ; Immunoglobulin G* ; Immunoglobulins ; Male ; Miller Fisher Syndrome* ; Neurologic Examination ; Ophthalmoplegia ; Plasma ; Visual Acuity

The present study evaluated the effects of a mixture of Galla rhois and Cinnamomum cassia extracts (GCE) (1 : 1, w/w) on susceptibility to the colonization of Campylobacter (C.) jejuni in broilers. Eighty two-week-old broilers (n = 20 per group) were used to estimate the efficacy of GCE against C. jejuni infection via drinking water. Antibacterial activity testing revealed that the minimum bactericidal concentration of GCE against C. jejuni was 2.5 mg/mL. Broilers challenged with C. jejuni were administered 0.0 (Non-GCE), 2.5 (GCE-2.5), 5.0 (GCE-5.0) and 10.0 g/L (GCE-10) GCE for 7 days, and the cecal contents were collected from five broilers per group on the 1st, 3rd, 5th, and 7th day post-treatment. On day 3 post-administration, the number of C. jejuni in GCE-5.0 (p < 0.05) and GCE-10 (p < 0.01) was significantly decreased relative to Non-GCE, while on day 7 those in all GCE-treated groups were significantly decreased compared to the Non-GCE group (p < 0.001). Hematological and blood biochemical analysis revealed no significant differences in parameters between the Non-GCE and GCE-treated groups. Based on the results of the present study, GCE was identified as a safe and alternative candidate to suppress C. jejuni colonization in broilers.
Campylobacter jejuni* ; Campylobacter* ; Chickens* ; Cinnamomum aromaticum* ; Cinnamomum* ; Colon* ; Drinking Water

Reliable transport of Campylobacter jejuni isolates is critical to microbial epidemiology research, especially in developing countries without a good temperature control mailing system. Various factors, including oxygen, temperature, transport medium composition, could affect the survival of C. jejuni. In this study, the protective effects of different ingredients in C. jejuni transport media at 4 °C and 25 °C and under aerobic condition were quantitatively evaluated respectively. The results showed that enriched medium, supplementation with 5% blood and being kept at 4 °C could improve the viability of different C. jejuni strains during transport. In addition, supplementation with 25 mmol/L L-fucose in Wang's transport medium could significantly improve the survival of C. jejuni at both 4 °C and 25 °C. To the best of our knowledge, this is the first report to evaluate the protective effect of L-fucose in enriched C. jejuni transport medium which is feasible in developing countries without an effective cold chain mailing system. These data will be good reference for C. jejuni transport medium improvement in future.
Bacteriological Techniques ; Campylobacter jejuni ; Culture Media

OBJECTIVETo determine Campylobacter contamination level and antimicrobial resistance patterns from chicken carcasses in supermarkets and farmer's markets of 9 districts in Beijing.

METHODSFrom August 2012 to July 2013, whole chicken carcasses (n = 240) were collected from 27 supermarkets and 18 farmer's markets of nine districts in Beijing. The level of Campylobacter contamination was enumerated by plate counting method using the modified Karmali and modified Preston agar. Presumptive Campylobacter isolates were identified and characterized by gram stain, agglumination test and a multiplex PCR method. The level of Campylobacter contamination was calculated following the USDA/FSIS Campylobacter enumeration method. Selected 151 Campylobacter isolates were further characterized by minimal inhibitory concentrations(MICs) of eight antimicrobials.

RESULTSA total of 26.3% (63/240) of the retail whole chicken carcasses were contaminated by Campylobacter and 151 Campylobacter isolates were recovered, including 85 Campylobacter jejuni isolates and 66 Campylobacter coli isolates. The P25, P50, P75 of Campylobacter contamination concentration were 7.5, 45.0 and 350.0 CFU/g, respectively. The antimicrobial resistance rate of C. jejuni and C. coli were as the following: azithromycin(AZI, 13% (11/85), 82% (54/85)), chloramphenicol (CHL, 33% (28/85), 42% (28/85)), ciprofloxacin (CIP, 95% (81/85), 100% (85/85)), doxycycline (DOX, 38% (32/85), 80% (53/85)), erythromycin (ERY, 12% (10/85), 82% (54/85)), gentamicin (GEN, 25% (21/85), 68% (45/85)), tetracycline (TET, 67% (57/85), 73% (62/85)), all isolates were susceptible to meropenem (MEP). The multi-drug resistance ratio of C. jejuni (55% (47/85) )was significantly lower than that (86% (57/66) )of C. coli (χ(2) = 16.70, P < 0.01). Among 151 Campylobacter isolates, 21 antimicrobial resistance patterns were identified, including 20 patterns among C. jejuni isolates and 10 patterns among C.coli isolates. Among C.jejuni isolates, CIP-DOX-TET was dominant (22% (19/85)), followed by CIP-TET (14% (12/85)), CHL-CIP-TET(9% (8/85)) and CHL-CIP-GEN (7% (6/85)). Among C.coli isolates,AZI-CHL-CIP-DOX-ERY-GEN-TET (35% (23/66)) was the dominant, followed by AZI-CIP-DOX-ERY-GEN-TET (21% (14/66) )and AZI-CIP-DOX-ERY-TET(15% (10/66)).

CONCLUSIONOur findings showed a high prevalence and concentration of Campylobacter contamination in retail chicken carcasses of nine districts in Beijing, especially the on-site slaughtered chicken from the farmer's markets. The resistance levels of these recovered Campylobacter isolates were serious.

Animals ; Anti-Bacterial Agents ; Campylobacter coli ; classification ; drug effects ; Campylobacter jejuni ; classification ; drug effects ; Chickens ; Drug Resistance, Multiple, Bacterial ; Food Microbiology ; Meat ; Microbial Sensitivity Tests

Campylobacter jejuni commonly causes bacterial enteritis but rarely causes extraintestinal infection including bacteremia. We isolated C. jejuni from the blood culture of a 20-year-old man presenting with fever and headache and also from the blood culture of a 23-year-old man suffering abdominal pain and diarrhea. This organism grew in anaerobic culture, showed curved Gram-negative bacilli by Gram stain, and was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).
Abdominal Pain ; Bacteremia* ; Campylobacter jejuni* ; Diarrhea* ; Enteritis ; Fever ; Headache ; Humans ; Mass Spectrometry ; Young Adult